| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2969819 | The Journal of Heart and Lung Transplantation | 2016 | 6 Pages |
Abstract
The new ISHLT pAMR grading schema identifies patients at increased risk of CV mortality, consistent with risks published from several programs before 2011. The current schema is validated by this analysis in a large biopsy database. Because pAMR1h, pAMR1i, and pAMR2 have similar CV risks associated with them, the threshold for a positive diagnosis of pAMR should be re-evaluated in future iterations of the ISHLT schema.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
M. Elizabeth H. MD, Monica P. MD, PhD, Dylan V. MD, Gregory L. PhD, Deborah MD, Josef MD, Kimberly M. MD, Craig H. MD, Stavros G. MD, PhD, Rami A. MD, Jose N. MD, Bruce B. MD, Abdallah G. MD,